Forecast

There is no analyst data available for this company.

News Go to news feed

Viromed Medical: executive Perbandt sells 50,000 shares

Heike Perbandt reduced her holding in Viromed Medical by 50,000 shares at €6.25 each on 9 September 2026. The filing with regulators was published on 14 September 2026; the stock showed losses on the day of the sale but turned positive after the publication. Earlier, Uwe Perbandt increased his stake by 2,000 shares at €5.65 on 4 September 2026. Viromed Medical has a market capitalization of €115.43 million and 20,250,000 tradable shares. » More on finanzen.net
Viromed Medical: executive Perbandt reduces holding by 10,000 shares

Viromed Medical reported to BaFin a managers’ transaction dated 10.09.2026, officially executed on 14.09.2026: Heike Perbandt reduced her closely associated holding by 10,000 shares at €6.10 each. Earlier, on 09.09.2026, Perbandt had already sold 50,000 securities at €6.25 apiece. The share rose slightly in FSE trading after the disclosures; market capitalization is currently around €115.43 million with a free float of 20.25 million shares. » More on finanzen.net
Viromed Medical: board member buys 11,300 shares via XETRA

Board member Uwe Perbandt reported purchases of a total of 11,300 Viromed Medical shares on 4 September 2026 via XETRA. The transactions were executed at individual prices of 5.60 EUR and 5.70 EUR, with an aggregate volume of 11,300 shares at an average price of 5.65 EUR. The transaction was publicly reported in accordance with statutory transparency obligations. » More on de.investing.com